F19.2
Other psychoactive substance dependence
Clinical Classification Guidelines
Excludes Type 1
- other psychoactive substance abuse (F19.1-)
- other psychoactive substance use, unspecified (F19.9-)
Medical Intelligence & Overview
Other psychoactive substance dependence (ICD-10 Code F19.2) refers to a condition where an individual develops a dependency on psychoactive substances that are not classified under specific categories like alcohol or opioids. This dependence can significantly impact daily life, health, and social relationships. It encompasses various substances that alter mental state and behavior, leading to compulsive use despite harmful consequences. Recognizing the signs and understanding the background of this dependence can help in seeking appropriate support and management.
Causes & Symptoms
Clinical Causes: Repeated exposure to psychoactive substances leading to tolerance and dependency Genetic predisposition affecting individual susceptibility Psychological factors such as stress, anxiety, or depression Environmental influences including peer pressure or availability of substances Underlying mental health disorders that increase vulnerability Misuse or recreational use that escalates over time Lack of awareness about the risks associated with specific psychoactive substances
Key Symptoms: Craving or intense desire to use the substance Inability to reduce or control substance use Withdrawal symptoms when not using the substance, such as sweating, nausea, or irritability Neglect of responsibilities at work, school, or home Continued use despite knowing the negative effects Spending significant time obtaining, using, or recovering from the effects Developing tolerance, needing increased amounts for the same effect Social withdrawal or isolation Changes in mood or behavior, including agitation or euphoria
Diagnostic & Treatment
Diagnosis Path: Diagnosing other psychoactive substance dependence involves a comprehensive evaluation by a healthcare professional, including detailed history taking and clinical assessment. Standardized questionnaires or screening tools may be used to identify patterns of use and dependency. Medical professionals also assess the impact of substance use on daily functioning and look for signs of withdrawal. Laboratory tests, such as blood or urine screens, can support diagnosis by detecting specific substances. The diagnosis aligns with criteria outlined in psychiatric manuals like the DSM-5 or ICD-10, focusing on the presence of behavioral symptoms and physiological dependence.
Treatment Protocols: Treatment strategies aim to address physical dependence, psychological aspects, and social factors influencing substance use. Approaches include: - Medical detoxification to manage withdrawal symptoms - Psychotherapy, such as cognitive-behavioral therapy, to modify harmful behaviors and thoughts - Medication-assisted treatment (MAT), where appropriate, to reduce cravings or manage withdrawal - Support groups and counseling to promote sustained recovery - Developing coping skills and relapse prevention strategies - Addressing any co-occurring mental health conditions - Educating about substance use risks and fostering a supportive environment for recovery A multidisciplinary approach often provides the most effective support, tailored to the individual's specific needs and circumstances.
Clinical Advice & FAQs
Billing Guidance
Is F19.2 a billable ICD-10 code?
Yes, F19.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.2?
Clinical documentation must specify the nature of Other psychoactive substance dependence and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
